Please enter a valid ZIP code

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) with MixPro® continues to offer you flexibility in vial sizes

When treating a bleed Bleed
In hemophilia, a collection of blood in an area, such as a muscle or joint.
, you know every second counts. With our 8-mg vial, you may require fewer vials per bleed—reducing preparation time and allowing faster access to treatment.

vials

Each vial comes with an appropriately prefilled syringe with diluent.


vial comparison

Products scaled proportionally from actual size.

Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information and Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.